TSPO and myeloid sarcoma: In neurodegenerative disorders, such as AD, PD, MS, Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), TSPO was found to be highly expressed at sites of injury and in microglia and astrocytes [107,118,123].